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Introduction
Computational simulation of biology, and of cancer, is an 
active and increasingly rich area of research.1–3 In in silico 
environments,  simulation-based  studies  and  experiments 
can be relatively inexpensive in cost, time, and risk, where 
simulations can be used as tools for hypothesis testing and 
predictive treatments. The trend in cancer modeling in recent 
years has been toward the development of multiscale models. 
Such models allow us to capture the interdependence of bio-
logical phenomena that occur at different biological scales, 
for example combining models of subcellular processes with 
cell–cell interactions, as opposed to single-scale models that 
might operate at one of these scales in isolation. They offer a 
natural framework for studying phenomena, such as cancer, 
which are inherently multiscale in nature, and thus appear 
to offer the cutting edge with regard to potential predictive 
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power  and  clinical  applicability.  There  are  generally  two 
kinds  of  modeling  approaches4:  a  bottom-up  approach 
that looks at simulation from a functional and reduction-
ist point of view, integrating multiple functional models of 
low-level processes; and a top-down approach that is formu-
lated from holistic observations of biological phenomena to 
develop models that fit observed behaviors and outcomes.   
In cancer modeling, both of these approaches are used to 
investigate  and  simulate  different  aspects  of  cancer,  and 
there is an increasing interest in combining mathematical 
modeling  techniques  in  a  hybrid  fashion.  Alas,  as  these 
models are typically created in isolation, interoperability is 
very rarely designed into the system.
One of the best hopes for developing novel models of 
cancer  that  span  multiple  biological  scales  is  to  reuse  and 
extend existing models. However, the integration or exten-
sion of existing models of cancer (or elements of those models) 
currently represents a substantial technical challenge in the 
field.5 Composition of models or model components typically 
relies on specialist domain knowledge about model constructs, 
intended  interactions,  computational  interfaces,  as  well  as 
application  domain  knowledge,  for  example,  the  underly-
ing biochemistry. Thus, a prerequisite for composing models 
is being able to reason semantically about commonalities or 
links between different models.
Efforts to relate data and models to domain knowledge 
are common in biology as the amount and diversity of data 
requires standards and structures in order to effectively manage 
it. Mature examples of open standards and ontologies include 
MicroArray and Gene Expression - Tabular format (MAGE-
TAB),6 Biological Pathway Exchange (BioPAX),7 and the Gene 
Ontology (GO)8,9 to name but a few. Computational models 
can also be thought of as a kind of data, where the plethora of 
published models also need standards and structures. Mature 
standards for functional descriptions of computational models 
include markup languages such as CellML10,11 and the Sys-
tems Biology Markup Language (SBML).12,13 Dealing with 
the diversity of cancer models available has been discussed 
previously14 and is a continuing challenge in the wider context 
of biological modeling when considering numerous interoper-
ability efforts ongoing in biology, where at the time of writing 
there are over 545 published standards.15
The de facto technologies for linking knowledge to data lie 
within the Semantic Web stack, which includes a set of speci-
fications and languages including the Resource Description 
Framework (RDF),16 the Web Ontology Language (OWL),17 
SPARQL Protocol and RDF Query Language (SPARQL),18 
and  the  Semantic  Web  Rule  Language  (SWRL).19  These 
standards have been developed based on the philosophy of 
open data over the World Wide Web, and properties yielded 
by developing computational engines on data structures for 
logical inference. Advanced software has been developed for 
logical reasoning over linked data using these standards, such 
as HermiT20 and Pellet.21
While the Semantic Web technology stack is mature and 
its standards fully supported by the World Wide Web Consor-
tium (W3C), the primary aim of such a technology is to facil-
itate machine processing and interoperation in a distributed 
fashion across the Web. The approach presented in this paper 
makes the assumption that all of the data, both domain-spe-
cific knowledge and model descriptions, lie within the scope 
of a single database, where in silico cancer models are semanti-
cally linked within this context. The overheads levied by the 
Semantic  Web  technology  stack  no  longer  restrict  perfor-
mance for querying data and for within-database analytics.
Our work in this paper builds on TumorML, a domain-
specific  XML-based  markup  language  for  computational 
cancer  model  description22  based  on  our  experiences  and 
requirements23 from the European Commission’s Transatlan-
tic Tumor Model Repositories (TUMOR) project.24 The aim 
of the project was to develop a European-based digital cancer 
model repository to link and interoperate with a similar estab-
lished digital model repository (DMR) based in the United 
States, and developed by the Center for the Development of a 
Virtual Tumor (CViT).25 TumorML was developed to act as 
the standard communication format between elements of the 
TUMOR infrastructure, and to facilitate model exportation. 
Its schema was designed to allow marked-up cancer model 
descriptions to hold essential metadata for search and retrieval 
of models from online repositories, as well as the linking of 
models  via  their  computational  interfaces.  We  extend  and 
apply  TumorML  in  this  work  with  a  property  graph-based 
data  model 26  and  corresponding  database  implementation 
that semantically links model descriptions to each other via 
domain knowledge stored in a graph database.
A property graph is a simple graph that consists of nodes 
and edges (representing relationships), where each node and 
edge can possess properties that store specific values. A tra-
versal is how you query a property graph, navigating from 
starting nodes to related nodes according to an underlying 
algorithm. In contrast to traditional relational databases, que-
ries can be run on graph data that map more conventionally to 
real-world questions, as many queries deal with how entities 
are related rather than finding or filtering on individual prop-
erties of entities. For example, social networks are commonly 
expressed as graphs, where typical queries might map to ques-
tions such as “Who are Alice’s friends?” or “Does Alice have 
any friends within 2-degrees of separation from Bob?”. While 
directed graphs have been used in data management in biol-
ogy, graph models are typically used in describing biological 
data, such as metabolic and signaling pathways, taxonomies 
of terms, and structural and sequence data.27–29 Our approach 
is to combine metadata sets with representations of computa-
tional models, rather than with biological data itself.
Implementation
We store our graphs and queries in Neo4j, an open-source graph 
database written in the Java programming language.30 Neo4j Semantically linking cancer models
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was chosen as the graph database as it is a mature, open source, 
general-purpose  NoSQL  database  system  that  implements 
the  property  graph  data  model.  Neo4j  uses  its  own  query 
language  called  Cypher,  which  was  designed  to  be  expres-
sive of the domain at hand rather than of the data structures. 
Cypher queries are declarative statements that allow querying 
and updating of graphs. They can be formulated to create and 
delete nodes and relationships, update properties in the graph, 
as well as traverse the graph and match certain sub-graph pat-
terns. For example, given a graph consisting of nodes repre-
senting people, and relationships linking people as ‘friend of’, 
the Cypher query to ask the above question, “Who are Alice’s 
friends?”, may look like that shown in Listing 1.
In Listing 1, line 1 specifies to iterate through all nodes 
in the graph. Line 2 adds a constraint as only nodes that are 
connected to nodes containing the property name equating to 
the value “Alice” connected by the relationship FRIEND_OF. 
Line 3 returns each matching node based on lines 1 and 2. 
For brevity’s sake, we will not describe Cypher’s syntax and 
functionality here; a full introduction to the Cypher query 
language can be found in a book on Neo4j.31
Before loading any in silico cancer models into our graph 
database, we define how our models should link together via 
some  domain-specific  knowledge.  This  provides  the  con-
text for our investigation, where our semantic queries utilize 
domain knowledge in order to return relevant information. 
For example, given a model, A, we may formulate a query 
to ask the question, “What other models are classified in the 
same categories as A?” In a relational model, this query would 
match values in a particular column to the category value, 
whereas in a property graph model, this query traverses the 
database graphs to look for models that are connected to A via 
a node representing the category of A. In other words, from A 
we traverse to a node representing the category of that cancer 
model, then return the set of all other model nodes connected 
to that category node.
As  a  starting  point,  we  took  the  data  model  used 
in  the  TumorML  XML  schema  produced  out  of  the 
TUMOR  project.24  The  schema  allows  the  recording  of 
metadata  relating  to  cancer  model  descriptions  on  a  num-
ber  of  levels.  Firstly,  TumorML  stores  metadata  relat-
ing  to  the  model  description  documents  themselves.  This 
enables  basic  curation  using  Dublin  Core,32  linking  with 
relevant people and organizations using xCard,33 as well as 
referencing/citation  metadata  using  BibTeXML.34  Also,   
a TUMOR-specific taxonomy of cancer models was devel-
oped  allowing  for  categorization  of  cancer  models  stored 
within the project’s infrastructure.22 Secondly, abstract model 
descriptions  are  used  to  describe  the  functional  interfaces 
to modularized cancer models in a black box fashion where 
information flows through parameter descriptors. The markup 
is  inspired  by  xMML.35  Within  the  model  descriptions, 
implementation  metadata  such  as  hardware  and  software 
environment requirements to run associated code or binary 
implementations are included in TumorML model descrip-
tions. This allows computational engines to interpret and exe-
cute stored models, where appropriate. The entity-relationship 
diagram in Figure 1 illustrates this data model. Meanwhile, 
Tables 1 and 2 summarize our mappings from the concepts 
outlined in Figure 1 to property graph concepts.
We  initially  loaded  in  three  different  domain- 
specific property graphs taken from within the TumorML 
schema:  a  Tumor  Model  Metadata  model;  a  data  model 
of  computational  types  (eg,  Strings,  Integers,  etc.);  and  a 
data model representing units (SI units and additional rel-
evant units). Figure 2 shows a visualization of our Tumor 
Model  Metadata  model  that  is  based  on  the  TUMOR 
model  taxonomy.  What  we  can  see  here  is  a  hierarchy 
where  the  endpoints  of  the  graph  represent  taxa  relating 
to  each  classifier.  For  example,  the  mathematical  tech-
nique utilized, labeled Math, can take one of three values –   
Continuous, Discrete, or Hybrid, and SingleScale models 
may be representative of phenomena acting on specific scales, 
such as Organ or Subcellular. When new model descriptions 
are  added  to  the  graph  database,  they  are  categorized  by 
connecting them to the relevant taxon. The edges connecting 
models to this domain-specific portion of the graph allow us 
to group related models together.
Listing 1. An example Cypher query to find friends of Alice.
is
is
has metadata
has output has input
in
has metadata
contains
Parameter
Unit
Term
CLI data type
Reference
Model
Category
Organization Person
figure 1. entity-relationship diagram showing the tumormL data 
model. Here, we can see that a model has input and output Parameters. 
Parameters are classified by Unit and Command Line Interface (CLI) data 
types, and also have metadata terms attached to them. other metadata 
includes bibliographic references, People, and organizations, as well as 
Categories to classify the model. models can also be compositions and 
contain other models.Johnson et al
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We also load into the database domain property graphs to 
represent model parameter types and their units. The purpose 
of these is particularly relevant in the context of componen-
tized cancer models, where linking model parameters to type 
and unit metadata allows us to describe how components may 
communicate with each other based on their computational 
interfaces  and  semantic  compatibility.  For  example,  the 
output of one component model may be a double-precision 
floating-point number, where its value represents a chemical 
concentration  level  of  the  phosphorolase-53  growth  factor, 
expressed as molar concentration in µM (M = moles/liter). 
Therefore, it should only be able to connect to another model 
via an input with the same parameter profile (type = double-
precision floating-point number; unit = µM). Where types 
and units are imprecise, for example, if the unit were in nM 
rather than µM, a computational execution environment, such 
as a workflow engine or simulation software, might still allow 
these parameters to be connected by identifying and normal-
izing these differences in scales. Likewise, type conversions 
and other unit conversions could also take place. With our 
graph database populated with three kinds of domain prop-
erty  graphs  (model  categorizations,  computational  types, 
units), we can load in our cancer model descriptions. Where 
in TumorML, metadata fields are used to annotate portions of 
models with domain-specific ontology or controlled vocabu-
lary terms, in our graph database, we now create direct links 
to nodes that exist in our domain property graphs to annotate 
the models.
Our approach described so far relies on the graph data-
base being pre-loaded with relevant domain information in 
order to link our cancer models. However, we can also add 
domain  information  to  our  domain-specific  graphs  on  the 
fly by making use of external services to semantically enrich 
the graph database, without having to convert and load entire 
controlled vocabularies or ontologies into our graph database. 
As an example, we use NCBO’s BioPortal,36 an open reposi-
tory of biomedical ontologies that provides access via Web 
services and Web browsers to ontologies developed in OWL, 
RDF, OBO format,37 and Protégé38 frames. Instead of load-
ing an entire ontology or vocabulary downloaded from Bio-
Portal, we query BioPortal for one particular term to annotate 
a model. In our case, we may seek to annotate a model input 
or output parameter. An appropriate BioPortal query allows us 
to retrieve a relevant term along with its synonyms and then 
store these as new property graphs in Neo4j. For this work, 
we have limited our scope to the NCI thesaurus39 (NCIt), as it 
is a rich and established collection of terms with good cover-
age for cancer research domains, which includes community 
standards, such as CDISC.40 This way, models are linked via 
NCIt codes, or by terms deemed synonymous with each other 
(including abbreviations), allowing property graph queries to 
traverse between models linked by common terminology. This 
could be easily extended to also relate coded terms together via 
BioPortal’s user-submitted mappings that would allow graph 
traversals  between  terms  taken  from  a  variety  of  different 
vocabularies and ontologies.
results
To illustrate how we apply our property graph model, and also 
how to link together models expressed as graphs, we present 
two examples: one for describing a single model translated 
from TumorML and the other for mapping a domain-specific 
Table 1. Details of relationships in our property graph model that 
map to the entity-relationship representation shown in figure 1. 
these relationships roughly translate to those shown in the entity-
relationship diagram of the tumormL data model shown in figure 1. 
for example, the relationship Has_InPUt links a model to an input 
Parameter. We have extended the tumormL data model slightly, for 
example introducing the sYnonYm_of_term relationship that 
links synonymous terms together.
RELATIoNShIP TYPE dESCRIPTIoN
Has_InPUt Connects a model with its input  
parameters
Has_oUtPUt Connects a model with its output  
parameters
Has_metaData Connects models and parameters to  
metadata
Has_CateGorY Connects categories with other  
categories (ie, subcategories)
ContaIns Connects a model with other sub- 
models (to show model composition)
sYnonYm_of_term Connects terms with synonymous terms
CreateD_BY Connects a model with a creator  
(or author) of the model
ContrIBUteD_BY Connects a model with a publisher  
of the model description (ie, the  
database record)
 
Table 2. Details of node types in our property graph model that 
map to the entity-relationship representation of the tumormL data 
model shown in figure 1. the node types in our graphs map directly 
to the entities in the tumormL data model. note, we have not 
included CLI data types as the aim is not to enable the discovery 
of computational compatibilities, but rather for compatible models 
beyond implementation.
NodE TYPE dESCRIPTIoN
moDeL represents an abstract model description
Parameter represents a model interface parameter
CateGorY metadata representing a categorization of  
a cancer model
term metadata representing a controlled  
vocabulary term
UnIt metadata representing a unit of measurement
Person represents a person
orGanIsatIon represents an organization
referenCe represents a bibliographic reference linked  
to the modelSemantically linking cancer models
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modeling framework’s modules into individual property 
graphs that are linked via domain-specific semantics.
example 1: eGFr-erk pathway module. For our first 
example, we took an EGFR-ERK pathway module,41 which 
describes  the  Ras/Raf/mitogen-activated  protein  kinase 
(MEK)/extracellular-signal-regulated kinase (ERK) pathway 
that is a key signaling network, governing proliferation, dif-
ferentiation, and cell survival.42 Briefly, binding of epidermal 
growth factor (EGF) to EGF receptor (EGFR) produces a 
series of downstream effects through the activation of cell 
decision-making components.43 Pathway dynamics are regu-
lated by material balance and kinetic equations as well as by 
reaction rates that are dependent on the changes in concentra-
tions of pathway components over time, as done in many other 
modeling studies.44–46 Readers are encouraged to refer to the 
original article to have a further understanding of the model.
Here, the pathway module was modeled using TumorML, 
as  set  out  in  previous  work,22  and  we  transformed  the 
TumorML description into our graph-based representation. In 
Listing 2, we show the TumorML description of the EGFR 
module. In Listing 3, we show the same description expressed 
in a Cypher query that creates relevant nodes and edges to 
form a sub graph. Lines 19–24 of the Cypher query shown in 
Listing 3 create direct links to domain-specific graph nodes, 
in particular to those nodes in our TUMOR model taxonomy 
depicted in Figure 2. The EGFR-ERK module loaded into 
Neo4j using the Cypher query in Listing 3 yields the graph 
shown in Figure 3.
When we have multiple models stored in the same data-
base,  we  gradually  build  up  connected  property  graphs  of 
models clustered around metadata nodes that are part of the 
domain graphs. This enables us to formulate Cypher queries 
that ask questions about the connectedness of nodes. For exam-
ple, a query that returns the EGFR-ERK Pathway depicted in 
Figure 3 might ask the question, “What models use continu-
ous mathematics?”, where the graph database query would be 
“What model nodes are connected to the continuous node in 
our database?”. We express this query in Cypher in Listing 4.
Line 1 of this query seeks to set the context for the pat-
tern machine, iterating through all nodes. Line 2 attempts to 
match sub-graphs that consist of any node, n, connected by a 
relationship HAS_METADATA to a Continuous node. The 
Middle-out
HAS_CATEG...
HAS_CATEGO...
HAS_CAT...
HAS_CAT...
HAS_CATEG...
HAS...
HAS...
HAS_CATEGORy
HAS_CATEGORY
HAS_CATE...
HAS_CATEGORY
HAS_CATEG...
HAS_CATEGO...
HAS_CATE...
HAS_CATEGO...
HAS_CATEG...
HAS_CATEGORy
HAS_CATEGO...
HAS_CATEGORy
HAS_CATEGORY
HAS_CATEGORY
HAS_CATEG...
HAS_CATEG...
HAS_CATEGO...
HAS_CATEGORY
Top-down
Bottom-up
Gene
Subcellular
Cell
Tissue
Organ
Single-scale
Breast
Glioma
Nephroblastoma
Cancer
Lung
Generic
Multi-scale
No
treatment
included
Tumor
model
metadata
Math
Homogeneity
Homogeneous
Non-homogeneous
Treatment
included
Discrete Continuous
Hybrid
figure 2. tUmor taxonomy transposed to a property graph model and visualized in the neo4j browser application. In this graph, we can see a hierarchy 
of categorizations. for example, the node Cancer has subcategories corresponding to Glioma, nephroblastoma, Breast, Lung, and Generic.Johnson et al
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1. <tumorml xmlns=http://www.tumor-project.eu/tumorml/1.2
      xmlns:xsi=http://www.w3.org/2001/XMLSchema-instance
      id="urn:miriam:tumor:000001">
2.    <header>
3.       <title>EGFR-ERK Pathway</title>
4.       <description>
5.           This is a multiscale agent-based model for investigating 
expansion dynamics of epithelial cancers (e.g., glioma, NSCLC)... 
6.       </description>
7.       <creator>
8.          <person id="urn:tumorml.org:user:000001">
9.              <fullname>Zhihui Wang</fullname>
10.          </person>
11.       </creator>
12.       <publisher>
13.          <person id="urn:tumorml.org:organisation:000001">
14.             <fullname>Complex Biosystems Modeling Laboratory (CBML) 
Massachusetts General Hospital</fullname>
15.          </person>
16.       </publisher>
17.       <contributor>
18.           <person id="urn:orcid:tumor:0000-0003-2850-3614">
19.               <fullname>Thomas S. Deisboeck, M.D.</fullname>
20.           </person>
21.       </contributor>
22.       <date>2012-06-22T00:00:00+00:00</date>
23.       <math>continuous</math>
24.       <scale>subcellular</scale>
25.       <biocomplexityDirection>bottomUp</biocomplexityDirection>
26.       <cancer>Lung Cancer</cancer>
27.       <homogeneity>homogeneous</homogeneity>
28.       <treatmentIncluded>false</treatmentIncluded>
29.    </header>
30.    <model>
31.        <parameters>
32.           <in name="egf" optional="0">
33.               <value type="double"/>
34.           </in>
35.           <out name="cell cycle time" optional="0">
36.               <value type="double"/>
37.           </out>
38.           <out name="PLC_g" optional="0">
39.               <value type="double"/>
40.           </out>
41.        </parameters>
42.    </model>
43. </tumorml> 
Listing 2. tumormL description of the eGfr-erK pathway module.
query then specifies to return the ID and Title properties of 
any matching nodes as a list. A selection of matching nodes is 
shown in Table 3 (this is not exhaustive for brevity).
example 2: Vascular tumor growth models. Our sec-
ond example deals with angiogenesis, an essential process in 
normal tissue evolution and maintenance. This physiological 
process provides blood, which brings with it oxygen and nutri-
ents, to many tumors allowing them to grow and spread. For 
many years angiogenesis has been a focus of intensive research, 
with several effective angiogenesis-related antitumor therapies 
developed by the pharmaceutical industry.47 Here, we focus 
on a family of models developed by Thomas Alarcón and col-
laborators  that  has  been  developed  into  an  object-oriented 
(OO) modeling framework for implementing hybrid and mul-
tiscale models of vascular tumor growth by the University of 
Oxford’s Department of Computer Science, in conjunction 
with the Wolfson Centre for Mathematical Biology. The focus 
of the framework development has been to apply software 
engineering techniques that allow its elements to be highly 
reusable and extensible. Models published by Alarcón et al, 
in particular the family of models discussed and extended 
in Ref. 48, have been reverse-engineered in order to extract 
and abstract the common methodologies and data structures 
involved in the development of vascular tumor growth mod-
els. The OO framework has been developed based on these 
abstractions, and a functioning implementation of the frame-
work has been developed in C++. The framework is presented 
fully by Connor et al in Ref. 49.
To demonstrate the use of our graph representation for 
exploring model composition, we loaded into our graph data-
base model descriptions of components of the tumor growth 
modeling framework described above. The reason for using 
such a framework for our exemplar is that it contains a coher-
ent, modular set of models that interoperate with each other in 
a predictable way. Thus, we are able to show how single-scale 
models can be linked together semantically to form multiscale 
models  within  the  context  of  existing  multiscale  models. 
Moreover, through the use of our graph-based data schema, Semantically linking cancer models
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Listing 3. Create: a Cypher query for creating the eGfr-erK pathway module in neo4j.
Lung
Homogeneous
Category
Person
Organisation
MEMBER_OF
CREATED_BY
PUBLISHED_BY
CONTRIBUTED
HAS_INP
HAS_OUTPUT
HAS_META...
HAS_META...
HAS_META...
HAS_META...
HAS_META...
HAS_META...
MEMBER_OF
Model
Parameter
No
treatment
included Zhihul
bill
wang
Complex
biosysiems
modeling
laboratory
(CBML),
massachusetts
general
hospital
Thomas
S.
Delsboeck
Subcellular
Continuous
PLCg
EGF
Cell
cycle
time
HAS_OUTPU
Bottom-up
EGFR-ERK
pathway
figure 3. the eGfr-erK pathway module as a property graph and visualized in the neo4j browser application.
model developers may explore the modeling framework with 
different kinds of queries that would not normally be straight-
forward without metadata and a means to compute over it.
In Figure 4 we have illustrated a portion of the vascular 
tumor growth framework, highlighting a simple case of inter-
facing with a model, using the Unified Modeling Language 
(UML) where the diagram was produced using Visual Para-
digm for UML,50 a computer -aided software engineering 
tool.  In  this  case,  objects  of  type  Alarcon2005SubCel-
lularModel interact with Cell objects that are collectively Johnson et al
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contained in a CellPopulation object. The parameters that 
are passed between the objects include chemical concentra-
tions, and information such as cell state, mass, and cycle 
times.  Listing  5  shows  the  corresponding  Cypher  query 
to create the property graph describing the Alarcón 2005 
subcellular model given in Ref. 51. After loading all of the 
framework’s model descriptions into the graph database, we 
can begin to explore our semantically linked models with 
Cypher queries.
We demonstrated earlier how we could link models by 
categorizations of cancer models. Now, using the example of 
the vascular tumor growth modeling framework, we can show 
how models can be linked less trivially through annotated 
model  inputs  and  outputs.  For  example,  queries  involving 
cancer model parameters might ask, “What cancer models have 
input parameters that are compatible with another model’s   
output parameters?”. Based on how we have linked our model 
parameters  and  variables  to  domain-specific  data,  such  as 
using our controlled vocabulary terms, standard units, and 
command-line data types, we can determine the most com-
patible single-scale models that could be used to compose a 
multiscale compound model. This can be expressed in Cypher 
as shown in Listing 6.
Line 1 seeks to iterate through all patterns of nodes, where 
the pattern consists of a model node n connected to an input 
parameter p, which is in turn connected to a metadata term 
meta that is shared with an output parameter q of a model 
m. Next, line 2 specifies that node n should not be the same 
as node m (to omit finding itself as a compatible model in the 
query). Finally, line 3 specifies to return all matches as a list 
of pairs of model titles under two headings, where ModelA   
has outputs that match inputs for ModelB, along with what 
terms are matched as NCIt codes. An example output to the 
query is shown in Table 4.
In this example, we can see that, based on the metadata terms 
with which model inputs and outputs are annotated, the outputs 
of the subcellular models are compatible with the inputs of the 
VEGF calculator models. Although the model para  meters have 
different labels (under table headings Output A and Input B),   
the annotated NCI terms ensure specific and identical meaning. 
C1272 corresponds to the NCIt code for Recombinant Vascu-
lar Endothelial Growth Factor (VEGF), and C28217 to the 
term for Intracellular. Explicitly, then, the combination of these 
terms indicates that the VEGF calculator components can be 
connected via intracellular VEGF to the Alarcón 2005 sub-
cellular model. Here, importantly, by capturing compositional 
relationships such as those that we know to exist between the 
Listing 4. Pattern matching: a Cypher query to find model nodes 
connected to both Imageable and continuous nodes.
Table 3. List of model node properties output from the example 
query in Listing 4.
Id TITLE
urn:miriam:tumor:000001 eGfr-erK Pathway model
urn:miriam:tumor:000004 alarcón 2005 subcellular model
urn:miriam:tumor:000005 owen 2011 subcellular model
urn:miriam:tumor:000007 alarcón 2005 VeGf calculator
urn:miriam:tumor:000008 alarcón 2006 VeGf calculator
 
SubCellularModel
ODEBasedSubCellularModel
Owen2011SubCellularModel
Alarcon2005SubCellularModel
RuleBasedSubCellularModel
Alarcon2003SubCellularModel
Cell state, cell mass, cell cycle time,
intracellular p53 concentration,
intracellular VEGF concentration,
intracellular oxygen concentration,
intracellular p27 concentration,
intracellular cyc-CDK complex
concentration, intracellular Cdh1
concentration, intracellular
non-phosphorylated RB concentration
Cell mass, cell cycle time, intracellular
p53 concentration, intracellular VEGF
concentration, intracellular oxygen
concentration, intracellular p27
concentration, intracellular cyc-CDK
complex concentration, intracellular
Cdh1 concentration, intracellular
non-phosphorylated RB concentration
Cell distribution
CellPopulation
Cell
figure 4. UmL class diagram illustrating parameters passed between subcellular models and cell objects.Semantically linking cancer models
141 CanCer InformatICs 2014:13(s1)
subcellular models and VEGF calculators in an existing family 
of multiscale models, we validate our approach.
Finally, another kind of query we may ask involves reason-
ing on compositional relationships between existing multiscale 
models. While the previous example uses Cypher to recom-
mend a composition, we may have stored models that we know 
are already composed of sub-models. Such compositions are 
denoted in our database by the CONTAINS relationship, as 
shown in Figure 5. This property graph expresses the fact that 
the Alarcón 2003 model is composed of a subcellular model, 
a  cell  proliferation  model,  a  vascular  structural  adaptation 
model, and an oxygen calculator. Each of these sub-models is 
associated with a specific single scale via appropriate metadata 
nodes. Questions such as “Over what biological scales does 
the Alarcon 2003 model extend?” are now possible. Clearly, 
an appropriately phrased query would return a list containing 
the Cell, Tissue, and Subcellular scales.
discussion
To  date,  many  computational  models  of  cancer  have  been 
developed to account for phenomena occurring at individual 
biological scales. One of the major challenges we now face is 
Listing 5. Create: a Cypher query to describe the alarcón 2005 sub cellular model shown in figure 4.Johnson et al
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Cell
Category
Model
Alarcon
03
cell
proliferation
model
Alarcon
03
CONTAINS
HAS_METADATA
HAS_METADATA
HAS_METADATA
HAS_METADATA HAS_METADATA
CONTAINS
CONTAINS
CONTAINS
Alarcon
03
model
Alarcon
03
subcellular
model
Vascular
structural
adaptation
model
Alarcon
03
Oxygen
calculator
Tissue
Subcellular Multiscale
figure 5. the alarcón 2003 model and its component models and 
biological scale metadata, represented as a property graph and 
visualized in the neo4j browser application.
Listing 6. Recommend compatible models: a Cypher query to find model 
nodes that have parameters that are compatible using metadata terms. 
Table 4. output of query on matching model outputs to inputs.
TERMS ModELA ModELb oUTPUT A INPUT b
C1272, 
C28217
alarcón 2005 
subcellular 
model
alarcón  
2005 VeGf  
calculator
vegf cellular_vegf
C1272, 
C28217
alarcón 2005 
subcellular 
model
alarcón  
2006 VeGf  
calculator
vegf cellular_vegf
to integrate and extend these models into a fully multiscale 
computational framework. However, model composition and 
extension is non-trivial, requiring specialist domain know-
ledge. Our approach intends to facilitate both the integration 
of single-scale models across multiple scales and the extension 
of existing multiscale models. We achieve this by enabling 
the annotation of cancer models and the formation of seman-
tic links between them through the use of a property graph 
database. Our approach, by making in silico models of can-
cer more understandable, also has the potential to close the 
gap between experimentalists and modelers and to encourage 
greater collaboration between them.
We believe that graph databases have a very relevant place 
in informatics systems for cancer study, and also more broadly 
in biomedical informatics. While semantic technologies are 
mature and well supported by organizations such as the W3C, 
much of the philosophy behind their development is based 
on interoperating systems for linked data across the Internet. 
With our tumor model graphs, we have taken the approach 
where metadata is stored alongside model descriptions, remov-
ing much of the overhead that comes with systems built on 
RDF and OWL. We, however, should make it clear that we 
do believe that the Semantic Web stack has its place and its 
uses. For importing and exporting data and metadata from a 
tumor model repository, we would certainly expect to leverage 
some or all of these technologies, and this is why the XML 
markup in TumorML was originally developed – to transmit 
such data in a standardized and interoperable format, which 
could be combined with the Semantic Web’s XML-based tools 
and formats.
In summary, we have presented a property graph model for 
representing tumor models so that combinations of models can 
be explored, based on semantic compatibility. A single graph 
database can be used to store domain data, such as taxono-
mies, controlled terminologies, and ontologies alongside model 
descriptions.  By  annotating  parameters  with  command-line 
interface data types, we can validate what might computationally 
fit together. Linking model descriptions to unit metadata allows 
us to reason about relative scalings between parameters, and by 
annotating with biological terms, as in the previous example 
using NCI codes, we can check the semantic compatibility 
of parameters based on biological knowledge (terms). We can 
then build relatively simple queries that propose links between 
models. In the future, we aim to build recommendation queries 
that could be quantified with compatibility metrics based on 
the proportions of common annotations, and also the distance 
of the metadata paths where terms might not match directly, 
but have common ancestry within ontologies or other relations 
between annotated terms.
To  date,  we  have  demonstrated  the  possibilities  for 
exploration of model composition using Cypher queries and 
a number of existing multiscale cancer model descriptions as 
test data. Efforts are underway to use this work as the basis for 
developing a set of usable software tools for exploring cancer 
models. In particular, we believe that the effective utilization 
of several modeling approaches: continuum models, discrete 
models as well as fitting of model parameters via biological 
and clinical data may be optimized using this methodology. 
The work described in this paper is fully available as an inter-
active demo and can be downloaded as a Neo4j GraphGist at 
http://gist.neo4j.org/?6038a7b526bfa48da2c0.
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